References
1.
Muchmore AV, Shifrin S, Decker JM: In vitro evidence that carbohydrate moieties derived from uromodulin, an 85,000 dalton immunosuppressive glycoprotein isolated from human pregnancy urine, are immunosuppressive in the absence of intact protein. J Immunol 1987;138:2547–2553.
2.
Kumar S, Muchmore A: Tamm-Horsfall protein-uromodulin (1950–1990). Kidney Int 1990;37:1395–1401.
3.
Ronco P, Dosquet P, Verroust P: La protéine de Tamm-Horsfall. Presse Méd 1988;17:1641–1646.
4.
Hession C, Decker JM, Sherblom AP, Kumar S, Yue CC, Mattalilano RJ, Kawashima E, Schmeissner U, Heletky S, Chow EP, Burne CA, Shaw A, Muchmore V: Uromodulin (Tamm-Horsfall glycoprotein): A renal ligand for lymphokines. Science 1987;237:1479–1484.
5.
Fletcher AP, Neuberger A, Ratcliff WA: Tamm-Horsfall urinary glycoprotein: The structure. Biochem J 1970;120:425–432.
6.
Rambausek M, Dulawa J, Jann K, Ritz E: Tamm-Horsfall glycoprotein in diabetes mellitus: Abnormal chemical composition and colloid stability. Eur J Clin Invest 1988;18:237–242.
7.
Williams J, Marshall RD, Van Halbeek H, Vliegenthart JFG: Structural analysis of the carbohydrate moieties of human Tamm-Horsfall glyocoprotein. Carbohydr Res 1984;134:141.
8.
Tamm I, Horsfall FL: Characterisation and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med 1950;74:108–114.
9.
Muchmore AV, Decker SM: Uromodulin: A unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science 1985;229:479–481.
10.
Pennica D, Kohr WJ, Kuang WJ, Glaister D, Aggarwal BB, Chen EY, Goeddel DV: Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein. Science 1987;236:83–88.
11.
Olczak T, Kubicz A, Kokot F, Duława J: Tamm-Horsfall protein isolated from urine of pregnant and non-pregnant women has similar oligosaccharides. Eur J Clin Invest 1998;28:475–482.
12.
Prasadan K, Bates J, Badgett A, Dell M, Sukhatme V, Kumar S: Nucleotide sequence and peptide motifs of mouse uromodulin (Tamm-Horsfall protein) – the most abundant protein in mammalian urine. Biochim Biophys Acta 1995;1260:328–332.
13.
Mendoza LM, Nishioka D, Vacquier VD: A GP1-anchored sea urchin sperm membrane protein containing EGF domains is related to human uromodulin. J Cell Biol 1993;121:1291–1297.
14.
Bork P, Sander C: A large domain common to sperm receptors (Zp2 and Zp3) and TGF-beta type III receptor. FEBS Lett 1992;300:237–240.
15.
Lopez-Casillas F, Payne HM, Andres JL, Massague J: Betaglycan can act as a dual modulator of TGF-beta access to signalling receptors: Mapping of ligand binding and GAG attachment sites. J Cell Biol 1994;124:557–568.
16.
Freedman SD, Sakamoto K, Venu RP: GP2, the homologue to the renal cast protein uromodulin, is a major component of intraductal plugs in chronic pancreatitis. J Clin Invest 1993;92:83–90.
17.
Ge AZ, Butcher EC: Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-β ligand. Gene 1994;138:201–206.
18.
Hoops TC, Rindler MJ: Isolation of the cDNA encoding glycoprotein-2 (GP-2), the major zymogen granule membrane protein. Homology to uromodulin/Tamm-Horsfall protein. J Biol Chem 1991;266:4257–4263.
19.
Rindler MJ, Naik SS, Li N, Hoops TC, Peraldi MN: Uromodulin (Tamm-Horsfall glycoprotein/uromucoid) is a phosphatidylinositol-linked membrane protein. J Biol Chem 1990;265:20784–20789.
20.
Brown D, Waneck GL: Glycosyl-phosphatidylinositol-anchored membrane proteins. J Am Soc Nephrol 1992;3:895–906.
21.
Badgett A, Kumar S: Phylogeny of Tamm-Horsfall protein. Urol Int 1998;61:72–75.
22.
Pook MA, Jeremiah S, Scheinman SJ, Thakker RV: Localization of the Tamm-Horsfall glycoprotein (uromodulin) gene to chromosome 16p12.3–16p13.11. Ann Hum Genet 1993;57:285–290.
23.
Bachmann S, Metzger R, Bunnemann B: Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle’s loop in rat kidney. Histochemistry 1990;94:517–523.
24.
Ronco P, Brunisholz M, Geniteau-Legendre M, Chatelet T, Verroust P, Richet G: Pathophysiologic aspects of Tamm-Horsfall protein: A phylogenetically conserved marker of the thick ascending limb of Henle’s loop. Adv Nephrol Necker Hosp 1987;16:231–249.
25.
Zimmerhackl LB, Rostasy K, Weigele G, Rasenach A, Wilhelm C, Lohner M, Brandis M, Kinne RKH: Tamm-Horsfall protein as a marker of tubular maturation. Pediatr Nephrol 1996;10:448–452.
26.
Praldi MN: Le point sur la protéine de Tamm-Horsfall. Néphrologie 1992;13:7–11.
27.
Costello CB, Sasani B, Kumar S: Tamm-Horsfall protein in human renal tumours. Anticancer Res 1991;11:2159–2162.
28.
Sikri KL, Foster CL, MacHugh N, Marshall RD: Localisation of Tamm-Horsfall glycoprotein in the human kidney using immunofluorescence and immunoelectron microscopical techniques. J Anat 1981;132:597–605.
29.
Bringuier AF, Seebold-Choqueux C, Moricard Y, Simmons DJ, Milhaud G, Labat ML: T-lymphocyte control of HLA-DR blood monocyte differentiation into neo-fibroblasts. Further evidence of pluripotential secreting functions of HLA-DR monocytes, involving not only collagen but also uromodulin, amyloid-beta peptide, alpha-fetoprotein and carcinoembryonic antigen. Biomed Pharmacother 1992;46:91–108.
30.
Duława J, Drab M, Drobisz M, Kokot F: Urinary excretion of Tamm-Horsfall protein in healthy subjects and patients with renal diseases. Nieren Hochdruckkr 1993;22(suppl):110–113.
31.
Goodall AA, Marshall RD: Effects of freezing and the estimated amounts of Tamm-Horsfall glycoprotein in urine, as determined by radioimmunoassay. Biochem J 1980;189:533–537.
32.
Ying WZ, Sanders PW: Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats. Kidney Int 1998;54:1150–1156.
33.
Dawnay AB, Catell WR: Serum Tamm-Horsfall glycoprotein level in health and renal disease. Clin Nephrol 1981;15:5–8.
34.
Alfaham M, Peters TI, Meyrick S, Avis P, Verrier Jones K: Serum Tamm-Horsfall protein levels in childhood: Relationship with age and glomerular filtration rate. Nephron 1989;52:216–221.
35.
Lynn KL, Marshall RD: The presence in serum of proteins which are immunologically cross-reactive with Tamm-Horsfall glycoprotein. Biochem J 1981;194:561–568.
36.
Hoyer SR, Seiler MW: Pathophysiology of Tamm-Horsfall protein. Kidney Int 1979;16:279–289.
37.
Hess B: Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 1994;20:393–398.
38.
Kitamura T, Pak CYC: Tamm and Horsfall glycoprotein does not promote spontaneous precipitation and crystal growth of calcium oxalate in vitro. J Urol 1982;127:1024–1026.
39.
Rose GA, Sulaiman S: Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: Quantitative studies. J Urol 1982;127:177–179.
40.
McQueen EG: The nature of urinary casts. J Clin Pathol 1962;15:367–371.
41.
Sanders PW, Booker BB: Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 1992;89:630–639.
42.
Thomas DBL, Davies M, Williams JD: Tamm-Horsfall protein: An etiological agent in tubulointerstitial disease? Exp Nephrol 1993;1:281–284.
43.
Resnick JS, Sissors S, Vernier KL: THP abnormal localisation in renal disease. Lab Invest 1978;38:550–555.
44.
Fasth AL, Hoyer SR, Seiler MW: Extratubular THP deposits induced by ureteral obstruction in mice. Clin Immunol Immunopathol 1988;47:47–61.
45.
Mayrer AC, Kashagarian M, Ruddle NH, Marier R, Hodson CS, Richards FF, Andriole VT: Tubulointerstitial nephritis and immunologic responses to Tamm-Horsfall protein in rabbits challenged with homologous urine or Tamm-Horsfall protein. J Immunol 1982;128:2634–2641.
46.
Grabska T, Bagiński T, Kubicz A, Kokot M, Kokot F, Duława J: Alterations of Tamm-Horsfall protein immunoreactivity after partial desialylation and deglycosylation. Arch Immunol Ther Exp (Warsz) 1996;44:241–248.
47.
Toma G, Bates JM, Kumar S: Uromodulin (Tamm-Horsfall protein) is a leukocyte adhesion molecule. Biochem Biophys Res Commun 1994;200:275–282.
48.
Mishra BB, Fernandes AM, Blaese RM, Muchmore AV: Characterization of T cell ligands for uromodulin: A possible role in costimulation. Cell Immunol 1994;159:113–123.
49.
Orskov I, Ferencz A, Orskov F: Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet 1980;i:887.
50.
Duława J, Rambausek M, Jann K, Ritz E: Tamm-Horsfall glycoprotein interferes with bacterial adherence to human kidney cells. Eur J Clin Invest 1988;18:87–92.
51.
Safirstein R, Megyesi J, Saggi SJ, Price PM, Poon M, Rollins BJ, Taubman MB: Expression of cytokine-like genes JE and KC is increased during ischemia. Am J Physiol 1991;261:F1095–F1101.
52.
Richet G: The mechanism of action of some loop-acting diuretics: Role of binding to Tamm-Horsfall protein. Clin Nephrol 1983;19(suppl):42–44.
53.
Mattey M, Naftalin L: Mechanoelectrical transduction, ion movement and water stasis in uromodulin. Experientia 1992;48:975–980.
54.
Janssens PM, Kuiper S, de Vries IH, Willems JL, Klasen I, van Oosterwijk M, Paardekooper J: Coating in vitro of erythrocytes with Tamm-Horsfall protein. Clin Chim Acta 1997;258:179–192.
55.
Fukushima K, Hara-Kuge S, Ohkura T, Seko A, Ideo H, Inazu T, Yamashita K: Lectin-like characteristics of recombinant human interleukin-1-beta recognizing glycans of the glycosylphosphatidylinositol anchor. J Biol Chem 1997;272:10579–10584.
56.
Su SJ, Chang KL, Lin TM, Huang YH, Yeh TM: Uromodulin and Tamm-Horsfall protein induce human monocytes to secrete TNF and express tissue factor. J Immunol 1997;158:3449–3456.
57.
Moonen P, Gaffner R, Wingfield P: Native cytokines do not bind to uromodulin (Tamm-Horsfall glycoprotein). FEBS Lett 1988;226:314–318.
58.
McLaughlin PJ, Aikawa A, Davies HM, Ward RG, Bakran A, Sells RA, Johnson PM: Uromodulin levels are decreased in urine during acute tubular necrosis but not during immune rejection after renal transplantation. Clin Sci (Colch) 1993;84:243–246.
59.
Sherblom AP, Decker JM, Muchmore AV: The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem 1988;263:5418–5424.
60.
Hession C, Decker SM, Sherblom A, Kumar S, Yue C, Mettaliano R, Tizard R, Kawashima E, Schneissner V, Heletky S, Chow P, Burne C, Shaw A, Muchmore A: Uromodulin (THP): A renal ligand for lymphokines. Science 1987;237:1479–1484.
61.
Sherblom AP, Sathyamoorthy N, Decker JM, Muchmore AV: IL-2, a lectin with specificity for high mannose glycopeptides. J Immunol 1989;143:939–944.
62.
Winkelstein A, Muchmore AV, Decker JM, Blaese M: Uromodulin: A specific inhibitor of IL-1-initiated human T cell colony formation. Immunopharmacology 1990;20:201–205.
63.
Muchmore AV, Sathyamoorthy N, Decker JM, Sherblom AP: Evidence that specific high mannose oligosaccharides can directly inhibit antigen-driven T-cell responses. J Leukoc Biol 1990;48:457–464.
64.
Smagula RM, Van Halbeek H, Decker JM, Muchmore AV, Sherblom AP: Pregnancy-associated changes in oligomannose oligosaccharides of human and bovine uromodulin (Tamm-Horsfall glycoprotein). Glycoconj J 1990;7:609–624.
65.
Fukushima K, Watanabe H, Takeo K, Nomura M, Asahi T, Yamashita K: N-linked sugar chain structure of recombinant human lymphotoxin produced by CHO cells: The functional role of carbohydrate as to its lectin-like character and clearance velocity. Arch Biochem Biopyhs 1993;304:144–153.
66.
Nesselhut T, Rath W, Grospietsch G, Weber MH, Kuhn W: Urinary protein electrophoresis profile in normal and hypertensive pregnancies. Arch Gynecol Obsted 1989;246:97–105.
67.
Austruy E, Cohen-Salmon M, Antignac C, Beroud C, Henry I, Nguyen VC, Brugières L, Jumien C, Jeanpierre C: Isolation of kidney complementary DNAs down-expressed in Wilms’ tumor by a subtractive hybridization approach. Cancer Res 1993;53:2888–2894.
68.
Labat ML, Bringuier AF, Seebold-Choqueux C, Moricard Y, Rault J, Jehanne M, Ferrec C, Milhaud G: Cystic fibrosis: Production of high levels of uromodulin-like protein by HLA-DR blood monocytes differentiating towards a fibroblastic phenotype. Biomed Pharmacother 1991;45:387–401.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
